The LCA5 gene helps the light sensing cells in the retina keep their tiny transport system working. This gene helps your body support normal vision, especially early in life. When both copies carry disease causing variants, the retina may not work as it should, which can lead to Leber congenital amaurosis or a similar early retinal condition with severe vision loss, poor visual tracking, and sometimes rapid, involuntary eye movements. The LCA5 gene is mainly known in eye genetics rather than popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the working parts of cells. Others mainly help determine when, where, and how strongly certain processes take place. Altogether, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more in-depth look at this topic, you can learn more in the LearnHub.
Overview
LCA5Gene function
What if the gene works
The LCA5 gene helps make lebercilin, a protein that supports tiny transport pathways in the retina’s light sensing cells. This helps those cells build and maintain the parts needed to detect light and support vision.
Risk
What if the gene does not work
When the LCA5 gene does not work properly, retinal light sensing cells fail, often causing severe vision loss from infancy or early childhood. Milder and more severe variants can influence when symptoms begin and how much vision remains.
Treatment
What does that mean for your treatment
At present, no treatment or management approach tied specifically to the LCA5 gene is established in clinical guidelines for people with a pathogenic variant. The LCA5 gene is being studied as a target for gene replacement therapy in inherited retinal disease, but this remains investigational.
Conditions associated with LCA5
Gene function
What if the gene works
In the retina, the LCA5 gene helps light sensing cells keep a tiny transport bridge working smoothly. This allows important proteins and cell parts to move to the area that captures light. It supports the normal day to day upkeep of these cells and the organized structure they need for vision.
In retinal light sensing cells, the LCA5 gene helps maintain the connecting cilium, a tiny bridge between cell compartments. This bridge keeps the cell organized and lets materials reach the light catching area.
Its protein supports the controlled movement of key visual proteins through that bridge into the outer segment, the part that responds to light. This is a central part of what the LCA5 gene does in the eye.
Photoreceptor cells renew their light catching parts every day. The LCA5 gene helps keep that renewal process supplied with the materials and building blocks those cells need.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LCA5 gene can shorten, destabilize, or sharply reduce lebercilin, which then disrupts movement of key proteins through the narrow bridge inside retinal light sensing cells. This helps explain how LCA5 gene variants affect retinal cells in Leber congenital amaurosis. Milder variants may leave some protein activity, while more disruptive variants often leave little or none. That difference can influence how early vision problems begin and how severe they become.
How variants are linked to conditions
Pathogenic variants in the LCA5 gene cause LCA5-related Leber congenital amaurosis, an inherited retinal condition that usually begins in infancy with marked vision loss. Some people with variants in the LCA5 gene are diagnosed with early-onset retinal dystrophy, a closely related condition label used when reduced vision, poor night vision, or rapid eye movements appear very early in life. Finding disease-causing variants in both copies of the gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are commonly found in the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LCA5, risk is mainly set by genetics, especially whether someone inherits disease-causing changes in both copies of the gene. Family history and whether both biological parents carry an LCA5 change are the main factors that affect the chance of having a child with this eye condition. There is not enough evidence to say that lifestyle or environmental factors change this risk.
Inheritance of LCA5 variants
LCA5-related conditions are inherited in an autosomal recessive pattern, which means a child usually needs to inherit one altered copy of the LCA5 gene from each parent. In families asking how variants of the LCA5 gene are inherited, this usually means both parents are healthy carriers. When both parents carry a variant in the LCA5 gene, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variant. This pattern affects sons and daughters equally.
What does my LCA5 result mean for my family?
For families with an LCA5-related eye condition, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other relatives could carry the same gene change without knowing it. This can matter for future pregnancies and for relatives who are planning children.
Genetic information
Genetic testing
How you find out about variants
LCA5 genetic testing looks for variants in the LCA5 gene using a blood or saliva sample. A lab reads the gene’s DNA code, often on an inherited retinal disease panel, to see whether a variant helps explain early severe vision loss such as Leber congenital amaurosis. Results may find two relevant variants, one, or none.
When should I consider getting a genetic test?
Genetic testing for the LCA5 gene may be considered when a baby or child has severe vision loss from birth or the first months of life, often with wandering eye movements or trouble tracking faces. It can also help when this kind of early inherited blindness runs in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help frame individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This is common and can influence how well a treatment works or how likely side effects are.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. More on this topic is available in the LearnHub.
Drugs influenced by the LCA5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so medication questions are best discussed with your doctor or pharmacist. If you have side effects, poor symptom control, or concerns when starting or changing a medicine, seek medical advice.
History
LCA5 entered the medical literature as researchers worked to explain rare inherited forms of severe vision loss beginning in early childhood. In recent decades, knowledge has built on a long tradition of observing inherited traits. A major step came in 2007, when pathogenic variants in the LCA5 gene were identified as a cause of Leber congenital amaurosis, helping clarify one subtype of this condition. The gene was named for lebercilin, reflecting its link to the Leber congenital amaurosis spectrum. From these first observations, research expanded steadily. That work helped connect LCA5 to a broader group of inherited retinal conditions and improved the way families could receive a precise genetic diagnosis.